Metastatic Uveal Melanoma Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05282901Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)Treatment